Maison Solutions Class A Common Stock Key Executives
This section highlights Maison Solutions Class A Common Stock's key executives, including their titles and compensation details.
Find Contacts at Maison Solutions Class A Common Stock
(Showing 0 of )
Maison Solutions Class A Common Stock Earnings
This section highlights Maison Solutions Class A Common Stock's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
Maison Solutions Inc., together with its subsidiaries, operates as the specialty grocery retailer in California. The company offers perishable products, such as meat, seafood, vegetables, and fruit; non-perishable products, including grocery products comprising cooking utensils, canned foods, Chinese and Asian seasonings and spices, and snacks, as well as liquor, cigarette, lottery, newspaper, reusable bag, non-food, and health products, and general merchandise, beauty care, pharmacy, fuel, and other items and services in its stores. It also offers its products online. The company was formerly known as Maison International, Inc. and changed its name to Maison Solutions Inc. in September 2021. Maison Solutions Inc. was incorporated in 2019 and is based in Monterey Park, California.
$1.02
Stock Price
$14.04M
Market Cap
-
Employees
Monterey Park, DE
Location
Financial Statements
Access annual & quarterly financial statements for Maison Solutions Class A Common Stock, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | April 30, 2024 | April 30, 2023 | April 30, 2022 | April 30, 2021 |
|---|---|---|---|---|
| Revenue | $58.04M | $55.40M | $41.98M | $41.20M |
| Cost of Revenue | $46.42M | $42.95M | $33.70M | $32.88M |
| Gross Profit | $11.62M | $12.45M | $8.29M | $8.31M |
| Gross Profit Ratio | 20.02% | 22.48% | 19.70% | 20.17% |
| Research and Development Expenses | $- | $- | $- | $- |
| General and Administrative Expenses | $4.17M | $3.89M | $3.00M | $1.75M |
| Selling and Marketing Expenses | $10.16M | $8.48M | $6.11M | $6.01M |
| Selling General and Administrative Expenses | $14.33M | $12.37M | $9.11M | $7.76M |
| Other Expenses | $- | $1.85M | $155.82K | $968.65K |
| Operating Expenses | $14.33M | $12.37M | $9.11M | $7.76M |
| Cost and Expenses | $60.75M | $55.32M | $42.81M | $40.64M |
| Interest Income | $- | $42.61K | $43.48K | $- |
| Interest Expense | $124.26K | $- | $- | $59.21K |
| Depreciation and Amortization | $461.87K | $370.53K | $437.41K | $578.87K |
| EBITDA | $-2.24M | $454.18K | $-389.18K | $1.13M |
| EBITDA Ratio | -3.86% | 0.82% | -0.93% | 2.75% |
| Operating Income | $-2.70M | $83.65K | $-826.59K | $553.40K |
| Operating Income Ratio | -4.66% | 0.15% | -1.97% | 1.34% |
| Total Other Income Expenses Net | $-242.46K | $1.89M | $199.30K | $909.44K |
| Income Before Tax | $-2.95M | $1.98M | $-627.29K | $1.46M |
| Income Before Tax Ratio | -5.08% | 3.57% | -1.49% | 3.55% |
| Income Tax Expense | $440.56K | $336.49K | $27.74K | $436.06K |
| Net Income | $-3.34M | $1.25M | $-562.74K | $904.08K |
| Net Income Ratio | -5.75% | 2.26% | -1.34% | 2.19% |
| EPS | $-0.19 | $0.07 | $-0.03 | $0.05 |
| EPS Diluted | $-0.19 | $0.07 | $-0.03 | $0.05 |
| Weighted Average Shares Outstanding | 17.91M | 18.50M | 18.50M | 18.50M |
| Weighted Average Shares Outstanding Diluted | 17.91M | 18.50M | 18.50M | 18.50M |
| SEC Filing | Source | Source | Source | Source |
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.15M | $31.02M | $29.65M | $16.93M | $13.60M | $13.77M | $13.75M | $14.18M | $15.64M | $14.17M | $11.41M | $10.91M | $11.47M |
| Cost of Revenue | $26.61M | $22.87M | $21.38M | $14.82M | $10.41M | $10.64M | $10.65M | $11.13M | $11.63M | $11.08M | $9.10M | $8.90M | $9.16M |
| Gross Profit | $7.54M | $8.15M | $8.27M | $2.10M | $3.19M | $3.12M | $3.11M | $3.05M | $4.01M | $3.08M | $2.30M | $2.01M | $2.32M |
| Gross Profit Ratio | 22.08% | 26.28% | 27.90% | 12.40% | 23.40% | 22.70% | 22.60% | 21.50% | 25.60% | 21.80% | 20.20% | 18.40% | 20.20% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $1.57M | $2.12M | $1.73M | $1.47M | $1.06M | $588.25K | $1.06M | $1.24M | $1.39M | $597.22K | $657.63K | $863.10K | $699.75K |
| Selling and Marketing Expenses | $4.85M | $5.36M | $4.90M | $3.17M | $2.44M | $2.28M | $2.26M | $1.81M | $2.66M | $1.84M | $2.17M | $1.31M | $1.80M |
| Selling General and Administrative Expenses | $6.43M | $7.48M | $6.63M | $4.54M | $3.49M | $2.87M | $3.32M | $3.05M | $4.06M | $2.44M | $2.83M | $2.17M | $2.50M |
| Other Expenses | $- | $- | $- | $36.39K | $898 | $-898 | $383.95K | $528.00K | $1.28M | $43.67K | $124 | $114.38K | $10.76K |
| Operating Expenses | $6.43M | $7.48M | $6.63M | $4.54M | $3.49M | $2.87M | $3.32M | $3.05M | $4.06M | $2.44M | $2.83M | $2.17M | $2.50M |
| Cost and Expenses | $33.03M | $30.35M | $28.01M | $19.36M | $13.91M | $13.51M | $13.97M | $14.18M | $15.69M | $13.52M | $11.93M | $11.07M | $11.66M |
| Interest Income | $- | $- | $- | $- | $- | $- | $- | $26.90K | $- | $- | $- | $85.28K | $- |
| Interest Expense | $269.06K | $242.38K | $183.39K | $28.30K | $19.43K | $29.96K | $46.57K | $- | $- | $28.76K | $31.59K | $- | $- |
| Depreciation and Amortization | $252.05K | $260.65K | $266.89K | $187.94K | $147.02K | $60.51K | $66.94K | $58.96K | $67.70K | $102.97K | $141.29K | $37.42K | $142.75K |
| EBITDA | $1.52M | $750.03K | $1.70M | $-2.25M | $-160.14K | $328.82K | $205.98K | $62.60K | $19.45K | $752.67K | $-379.71K | $-118.61K | $-43.15K |
| EBITDA Ratio | 4.46% | 2.42% | 5.75% | -13.27% | -1.18% | 2.39% | 1.50% | 0.44% | 0.12% | 5.31% | -3.33% | -1.10% | -0.38% |
| Operating Income | $1.11M | $671.37K | $1.63M | $-2.43M | $-307.17K | $253.82K | $-216.75K | $3.45K | $-48.25K | $649.44K | $-521.00K | $-156.03K | $-185.89K |
| Operating Income Ratio | 3.26% | 2.16% | 5.51% | -14.38% | -2.26% | 1.84% | -1.58% | 0.02% | -0.31% | 4.58% | -4.57% | -1.43% | -1.62% |
| Total Other Income Expenses Net | $-110.88K | $-424.37K | $-380.82K | $-466.47K | $-69.73K | $-15.19K | $308.93K | $554.90K | $1.35M | $14.91K | $-31.46K | $199.66K | $-6.00K |
| Income Before Tax | $1.00M | $247.00K | $1.25M | $-2.90M | $-376.90K | $238.64K | $92.18K | $558.36K | $1.31M | $664.35K | $-552.46K | $43.63K | $-191.90K |
| Income Before Tax Ratio | 2.94% | 0.80% | 4.23% | -17.14% | -2.77% | 1.73% | 0.67% | 3.94% | 8.35% | 4.69% | -4.84% | 0.40% | -1.67% |
| Income Tax Expense | $8.42K | $563.10K | $636.23K | $15.84K | $158.66K | $147.16K | $118.91K | $147.34K | $99.07K | $72.16K | $17.93K | $622 | $9.73K |
| Net Income | $1.01M | $-256.01K | $700.91K | $-2.78M | $-548.95K | $91.47K | $-104.94K | $331.18K | $988.47K | $529.19K | $-597.04K | $186.83K | $-219.45K |
| Net Income Ratio | 2.96% | -0.83% | 2.36% | -16.41% | -4.04% | 0.66% | -0.76% | 2.33% | 6.32% | 3.73% | -5.23% | 1.71% | -1.91% |
| EPS | $0.06 | $-0.01 | $0.04 | $-0.14 | $-0.03 | $0.01 | $-0.01 | $0.02 | $0.05 | $0.03 | $-0.03 | $0.01 | $-0.01 |
| EPS Diluted | $0.06 | $-0.01 | $0.04 | $-0.14 | $-0.03 | $0.01 | $-0.01 | $0.02 | $0.05 | $0.03 | $-0.03 | $0.01 | $-0.01 |
| Weighted Average Shares Outstanding | 17.45M | 17.45M | 17.45M | 19.69M | 19.41M | 16.78M | 18.50M | 19.00M | 18.50M | 18.50M | 18.50M | 19.00M | 19.00M |
| Weighted Average Shares Outstanding Diluted | 17.45M | 17.45M | 17.45M | 19.69M | 19.44M | 16.78M | 18.50M | 19.00M | 19.00M | 18.50M | 18.50M | 19.00M | 19.00M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | April 30, 2024 | April 30, 2023 | April 30, 2022 | April 30, 2021 |
|---|---|---|---|---|
| Cash and Cash Equivalents | $- | $2.57M | $898.06K | $714.28K |
| Short Term Investments | $1.10K | $- | $- | $- |
| Cash and Short Term Investments | $1.10K | $2.57M | $898.06K | $714.28K |
| Net Receivables | $1.85M | $1.19M | $4.84M | $2.23M |
| Inventory | $6.80M | $2.98M | $2.32M | $1.94M |
| Other Current Assets | $3.26M | $1.55M | $999.71K | $4.86K |
| Total Current Assets | $11.91M | $8.29M | $9.06M | $4.89M |
| Property Plant Equipment Net | $43.06M | $23.22M | $16.45M | $17.98M |
| Goodwill | $16.96M | $2.22M | $- | $- |
| Intangible Assets | $7.98M | $197.33K | $15.27K | $10.03K |
| Goodwill and Intangible Assets | $24.94M | $2.42M | $15.27K | $10.03K |
| Long Term Investments | $1.54M | $203.44K | $203.44K | $74.37K |
| Tax Assets | $15.14K | $457.49K | $301.20K | $-74.37K |
| Other Non-Current Assets | $962.45K | $1.10K | $74.37K | $377.12K |
| Total Non-Current Assets | $70.50M | $26.30M | $17.04M | $18.37M |
| Other Assets | $- | $- | $- | $- |
| Total Assets | $82.41M | $34.58M | $26.10M | $23.26M |
| Account Payables | $5.39M | $3.11M | $3.37M | $1.94M |
| Short Term Debt | $19.38M | $2.28M | $1.56M | $1.31M |
| Tax Payables | $442.52K | $990.01K | $474.34K | $440.86K |
| Deferred Revenue | $965.70K | $449.33K | $370.93K | $176.85K |
| Other Current Liabilities | $2.59M | $1.55M | $1.76M | $866.34K |
| Total Current Liabilities | $28.77M | $8.37M | $7.54M | $4.74M |
| Long Term Debt | $41.51M | $25.27M | $19.35M | $18.66M |
| Deferred Revenue Non-Current | $15.14K | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $1.27M | $40.41K | $- | $- |
| Other Non-Current Liabilities | $140.26K | $105.64K | $55.15K | $60.55K |
| Total Non-Current Liabilities | $42.92M | $25.42M | $19.40M | $18.72M |
| Other Liabilities | $- | $- | $- | $- |
| Total Liabilities | $71.69M | $33.79M | $26.95M | $23.45M |
| Preferred Stock | $- | $- | $- | $- |
| Common Stock | $1.97K | $1.60K | $1.60K | $1.60K |
| Retained Earnings | $-2.82M | $522.71K | $-729.09K | $-166.35K |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- |
| Other Total Stockholders Equity | $13.31M | $- | $- | $- |
| Total Stockholders Equity | $10.50M | $524.31K | $-727.49K | $-164.75K |
| Total Equity | $10.72M | $792.26K | $-847.04K | $-192.02K |
| Total Liabilities and Stockholders Equity | $82.41M | $34.58M | $26.10M | $23.26M |
| Minority Interest | $221.12K | $267.95K | $-119.55K | $-27.27K |
| Total Liabilities and Total Equity | $82.41M | $34.58M | $26.10M | $23.26M |
| Total Investments | $1.54M | $203.44K | $203.44K | $74.37K |
| Total Debt | $60.89M | $27.56M | $20.91M | $19.97M |
| Net Debt | $60.89M | $24.99M | $20.02M | $19.25M |
Balance Sheet Charts
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | April 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $445.36K | $355.67K | $588.90K | $- | $9.41M | $8.60M | $1.61M | $2.57M | $2.58M | $1.38M | $898.06K |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $445.36K | $355.67K | $588.90K | $- | $9.41M | $8.60M | $1.61M | $2.57M | $2.58M | $1.38M | $898.06K |
| Net Receivables | $86.96K | $105.73K | $1.32M | $1.85M | $2.19M | $1.14M | $1.14M | $1.19M | $1.72M | $1.97M | $4.84M |
| Inventory | $10.66M | $8.89M | $7.35M | $6.80M | $3.02M | $2.83M | $2.87M | $2.98M | $2.92M | $3.87M | $2.32M |
| Other Current Assets | $4.12M | $4.99M | $3.37M | $3.26M | $20.00K | $1.69M | $1.08M | $1.55M | $24.63K | $44.11K | $999.71K |
| Total Current Assets | $15.31M | $14.34M | $12.63M | $11.91M | $14.64M | $14.25M | $6.70M | $8.29M | $7.25M | $7.27M | $9.06M |
| Property Plant Equipment Net | $40.86M | $41.62M | $42.38M | $43.06M | $21.79M | $22.09M | $22.66M | $23.22M | $19.95M | $20.49M | $16.45M |
| Goodwill | $16.96M | $16.96M | $16.96M | $16.96M | $2.22M | $2.22M | $2.22M | $2.22M | $1.99M | $1.86M | $- |
| Intangible Assets | $7.56M | $7.70M | $7.84M | $7.98M | $3.07M | $1.69M | $193.80K | $197.33K | $509.84K | $521.82K | $15.27K |
| Goodwill and Intangible Assets | $24.52M | $24.66M | $24.80M | $24.94M | $5.29M | $3.91M | $2.42M | $2.42M | $2.50M | $2.38M | $15.27K |
| Long Term Investments | $1.10M | $1.17M | $1.33M | $1.54M | $2.01M | $1.63M | $1.61M | $203.44K | $203.44K | $203.44K | $203.44K |
| Tax Assets | $- | $- | $- | $15.14K | $457.49K | $457.49K | $457.49K | $457.49K | $457.49K | $463.14K | $301.20K |
| Other Non-Current Assets | $958.21K | $946.21K | $946.21K | $946.21K | $1.10K | $1.10K | $1.10K | $1.10K | $1.10K | $1.10K | $74.37K |
| Total Non-Current Assets | $67.44M | $68.40M | $69.45M | $70.50M | $29.56M | $28.09M | $27.15M | $26.30M | $23.11M | $23.53M | $17.04M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $82.74M | $82.74M | $82.08M | $82.41M | $44.20M | $42.35M | $33.85M | $34.58M | $30.36M | $30.80M | $26.10M |
| Account Payables | $10.50M | $9.06M | $7.49M | $5.39M | $1.65M | $2.96M | $2.95M | $3.11M | $2.40M | $4.04M | $3.37M |
| Short Term Debt | $9.74M | $14.03M | $16.11M | $19.38M | $1.97M | $2.17M | $2.22M | $2.28M | $2.20M | $2.14M | $1.56M |
| Tax Payables | $1.66M | $1.67M | $1.25M | $442.52K | $1.11M | $1.25M | $1.12M | $990.01K | $867.48K | $588.73K | $474.34K |
| Deferred Revenue | $- | $- | $897.81K | $965.70K | $308.33K | $317.15K | $370.84K | $449.33K | $254.16K | $275.10K | $370.93K |
| Other Current Liabilities | $4.90M | $5.23M | $2.66M | $2.59M | $1.55M | $1.62M | $1.48M | $1.55M | $2.08M | $1.88M | $1.76M |
| Total Current Liabilities | $26.81M | $29.99M | $28.41M | $28.77M | $6.60M | $8.31M | $8.14M | $8.37M | $7.80M | $8.93M | $7.54M |
| Long Term Debt | $42.57M | $40.37M | $40.95M | $41.51M | $23.82M | $24.31M | $24.80M | $25.27M | $21.94M | $22.51M | $19.35M |
| Deferred Revenue Non-Current | $- | $- | $- | $39.02M | $- | $- | $- | $- | $- | $105.72K | $- |
| Deferred Tax Liabilities Non-Current | $1.21M | $1.23M | $1.25M | $1.29M | $34.27K | $36.74K | $38.65K | $40.41K | $125.30K | $87.36K | $- |
| Other Non-Current Liabilities | $131.23K | $124.43K | $140.55K | $140.26K | $111.31K | $111.31K | $110.11K | $105.64K | $110.11K | $105.72K | $55.15K |
| Total Non-Current Liabilities | $43.92M | $41.73M | $42.34M | $42.92M | $23.97M | $24.46M | $24.95M | $25.42M | $22.18M | $22.70M | $19.40M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $70.73M | $71.72M | $70.75M | $71.69M | $30.56M | $32.77M | $33.08M | $33.79M | $29.98M | $31.63M | $26.95M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $1.97K | $1.97K | $1.97K | $1.97K | $1.97K | $1.85K | $1.60K | $1.60K | $1.60K | $1.60K | $1.60K |
| Retained Earnings | $-1.36M | $-2.37M | $-2.12M | $-2.82M | $-39.72K | $509.24K | $417.77K | $522.71K | $191.53K | $-796.94K | $-729.09K |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Total Stockholders Equity | $13.31M | $13.31M | $13.31M | $13.31M | $13.31M | $8.72M | $- | $- | $- | $- | $- |
| Total Stockholders Equity | $11.95M | $10.94M | $11.20M | $10.50M | $13.28M | $9.23M | $419.37K | $524.31K | $193.13K | $-795.34K | $-727.49K |
| Total Equity | $12.02M | $11.02M | $11.34M | $10.72M | $13.64M | $9.57M | $765.53K | $792.26K | $381.24K | $-825.23K | $-847.04K |
| Total Liabilities and Stockholders Equity | $82.74M | $82.74M | $82.08M | $82.41M | $44.20M | $42.35M | $33.85M | $34.58M | $30.36M | $30.80M | $26.10M |
| Minority Interest | $61.36K | $77.95K | $138.04K | $221.12K | $359.57K | $346.18K | $346.16K | $267.95K | $188.10K | $-29.89K | $-119.55K |
| Total Liabilities and Total Equity | $82.74M | $82.74M | $82.08M | $82.41M | $44.20M | $42.35M | $33.85M | $34.58M | $30.36M | $30.80M | $26.10M |
| Total Investments | $1.10M | $1.17M | $1.33M | $1.54M | $2.01M | $1.63M | $1.61M | $203.44K | $203.44K | $203.44K | $203.44K |
| Total Debt | $50.83M | $54.41M | $57.06M | $61.05M | $25.79M | $26.48M | $27.01M | $27.56M | $24.14M | $24.65M | $20.91M |
| Net Debt | $50.38M | $54.05M | $56.47M | $61.05M | $16.39M | $17.88M | $25.40M | $24.99M | $21.56M | $23.27M | $20.02M |
Annual Cash Flow
| Breakdown | April 30, 2024 | April 30, 2023 | April 30, 2022 | April 30, 2021 |
|---|---|---|---|---|
| Net Income | $-3.39M | $1.64M | $-655.03K | $1.03M |
| Depreciation and Amortization | $461.87K | $371.70K | $437.41K | $578.87K |
| Deferred Income Tax | $-11.70K | $-3.12K | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- |
| Change in Working Capital | $-1.04M | $-1.62M | $1.69M | $-528.08K |
| Accounts Receivables | $-67.98K | $-14.43K | $264.04K | $-411.68K |
| Inventory | $914.36K | $343.51K | $-391.26K | $-420.01K |
| Accounts Payables | $47.09K | $-751.33K | $1.43M | $-957.12K |
| Other Working Capital | $-1.93M | $-1.20M | $385.66K | $1.26M |
| Other Non Cash Items | $472.58K | $95.71K | $15.26K | $31.55K |
| Net Cash Provided by Operating Activities | $-3.50M | $484.19K | $1.49M | $1.11M |
| Investments in Property Plant and Equipment | $-382.13K | $-49.39K | $-63.79K | $-37.15K |
| Acquisitions Net | $-7.00M | $-2.50M | $- | $- |
| Purchases of Investments | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- |
| Other Investing Activities | $-4.83M | $4.41M | $-3.22M | $-1.19M |
| Net Cash Used for Investing Activities | $-12.21M | $1.86M | $-3.28M | $-1.23M |
| Debt Repayment | $-173.38K | $-746.64K | $1.98M | $-525.29K |
| Common Stock Issued | $13.31M | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- |
| Other Financing Activities | $- | $- | $- | $-125.70K |
| Net Cash Used Provided by Financing Activities | $13.14M | $-746.64K | $1.98M | $-650.99K |
| Effect of Forex Changes on Cash | $- | $- | $- | $- |
| Net Change in Cash | $-2.57M | $1.60M | $183.78K | $-768.07K |
| Cash at End of Period | $1.10K | $2.57M | $972.43K | $788.65K |
| Cash at Beginning of Period | $2.57M | $972.43K | $788.65K | $1.56M |
| Operating Cash Flow | $-3.50M | $484.19K | $1.49M | $1.11M |
| Capital Expenditure | $-3.33M | $-49.39K | $-63.79K | $-37.15K |
| Free Cash Flow | $-6.84M | $434.80K | $1.42M | $1.07M |
Cash Flow Charts
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $995.16K | $-316.10K | $617.83K | $-2.78M | $-535.56K | $91.48K | $-26.72K | $411.02K | $1.21M | $592.20K | $-570.39K | $43.01K | $-201.62K |
| Depreciation and Amortization | $252.05K | $260.65K | $266.89K | $187.94K | $147.03K | $60.22K | $67.24K | $59.15K | $67.70K | $103.35K | $141.50K | $35.93K | $142.75K |
| Deferred Income Tax | $-17.22K | $-23.61K | $-17.46K | $-5.56K | $-2.47K | $-1.91K | $-1.76K | $5.10K | $10.28K | $-18.21K | $-302 | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Change in Working Capital | $- | $-2.31M | $2.31M | $-396.32K | $-1.03M | $-254.22K | $637.89K | $-421.54K | $202.25K | $-2.34M | $940.52K | $775.52K | $-1.14M |
| Accounts Receivables | $18.77K | $234.13K | $-227.98K | $592.26K | $-550.19K | $-55.69K | $-54.36K | $780.54K | $-378.58K | $-344.15K | $-72.24K | $1.16M | $46.46K |
| Inventory | $-1.80M | $-1.65M | $-753.10K | $954.50K | $-195.74K | $44.41K | $111.17K | $100.95K | $732.49K | $-558.46K | $68.53K | $210.00K | $-158.07K |
| Accounts Payables | $1.44M | $1.57M | $2.09M | $1.37M | $-1.17M | $-11.49K | $-138.49K | $445.02K | $-647.67K | $-337.78K | $-210.90K | $-535.59K | $-1.07M |
| Other Working Capital | $1.27M | $-2.47M | $1.20M | $-3.31M | $892.50K | $-231.46K | $719.57K | $-1.75M | $496.01K | $-1.10M | $1.16M | $-60.24K | $47.33K |
| Other Non Cash Items | $448.62K | $3.51M | $411.41K | $-2.16M | $53.67K | $-16.00K | $-80.10K | $66.23K | $-66.34K | $87.52K | $8.31K | $-11.89K | $37.77K |
| Net Cash Provided by Operating Activities | $1.68M | $1.12M | $3.59M | $-2.62M | $-1.36M | $-120.44K | $596.54K | $119.97K | $1.42M | $-1.58M | $519.64K | $842.57K | $-1.16M |
| Investments in Property Plant and Equipment | $- | $- | $- | $-65.05K | $-1.44M | $-1.51M | $-12.81K | $-25.20K | $-11.69K | $-12.50K | $- | $-2.31K | $- |
| Acquisitions Net | $- | $- | $- | $-7.00M | $-742.43K | $- | $-1.44M | $- | $- | $-2.50M | $- | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $-435.00K | $- | $-1.44M | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $-21.34K | $-92.45K | $-102.63K | $- | $- | $- | $- | $- | $433.14K | $3.98M | $- | $-2.63M | $1.80M |
| Net Cash Used for Investing Activities | $-21.34K | $-92.45K | $-102.63K | $-7.07M | $-2.18M | $-1.51M | $-1.45M | $-25.20K | $421.45K | $1.46M | $- | $-2.64M | $1.80M |
| Debt Repayment | $-1.57M | $-1.26M | $-2.89M | $274.13K | $-245.56K | $-100.53K | $-101.42K | $-213.78K | $-610.66K | $-140.74K | $207.54K | $-60.38K | $1.61M |
| Common Stock Issued | $- | $- | $- | $- | $4.60M | $8.72M | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $- | $- | $- | $- | $- | $8.72M | $- | $108.54K | $-34.60K | $-62.93K | $- | $-386.94K | $253.16K |
| Net Cash Used Provided by Financing Activities | $-1.57M | $-1.26M | $-2.89M | $274.13K | $4.35M | $8.62M | $-101.42K | $-105.24K | $-645.26K | $-203.67K | $207.54K | $-447.31K | $1.87M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $89.69K | $-233.23K | $587.79K | $-9.41M | $805.28K | $6.99M | $-957.68K | $-10.48K | $1.20M | $-314.82K | $727.18K | $-2.24M | $2.51M |
| Cash at End of Period | $445.36K | $355.67K | $588.90K | $1.10K | $9.41M | $8.60M | $1.61M | $2.57M | $2.58M | $1.38M | $1.70M | $972.43K | $3.21M |
| Cash at Beginning of Period | $355.67K | $588.90K | $1.10K | $9.41M | $8.60M | $1.61M | $2.57M | $2.58M | $1.38M | $1.70M | $972.43K | $3.21M | $705.76K |
| Operating Cash Flow | $1.68M | $1.12M | $3.59M | $-2.62M | $-1.36M | $-120.44K | $596.54K | $119.97K | $1.42M | $-1.58M | $519.64K | $842.57K | $-1.16M |
| Capital Expenditure | $- | $102.63K | $-102.63K | $-65.05K | $-1.44M | $-1.51M | $-12.81K | $-25.20K | $-11.69K | $-12.50K | $- | $-2.31K | $- |
| Free Cash Flow | $1.68M | $1.22M | $3.48M | $-2.68M | $-2.80M | $-1.63M | $583.73K | $94.76K | $1.41M | $-1.59M | $519.64K | $840.26K | $-1.16M |
Maison Solutions Class A Common Stock Dividends
Explore Maison Solutions Class A Common Stock's dividend history, including dividend yield, payout ratio, and historical payments.
Maison Solutions Class A Common Stock News
Read the latest news about Maison Solutions Class A Common Stock, including recent articles, headlines, and updates.
Maison Solutions Appoints Xintong Ma as Chief Strategy Officer
MONTEREY PARK, CA / ACCESS Newswire / March 20, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, announced the engagement of Mr. Xintong Ma as its new Chief Strategy Officer in a consulting role.
Maison Solutions Reports Third Quarter and Nine-Month 2025 Financial Results
MONTEREY PARK, CA / ACCESS Newswire / March 17, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the third quarter and nine-months ended January 31, 2025. Management Commentary "The third quarter marked the first step in our mission to evolve beyond a traditional grocery chain into a solutions provider," said John Xu, President, Chairman, and Chief Executive Officer of Maison Solutions.
Maison Solutions Appoints Jacob Cao as Chief Operating Officer
MONTEREY PARK, CALIFORNIA / ACCESS Newswire / February 27, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, announced the appointment of Jacob Cao as its new Chief Operating Officer. In this role, Cao will oversee operating strategies with a focus on implementing new policies that aid Maison in its continued strategic expansion.
Maison Solutions to Participate in the 37th Annual ROTH Conference
MONTEREY PARK, CA / ACCESS Newswire / February 24, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, will be holding one-on-one meetings at the 37th Annual ROTH Conference from March 16-18, 2025, at the Laguna Cliffs Marriott in Dana Point, California. Company VP of Corporate Development and Strategy Chris Zhang will hold one-on-one meetings with institutional investors at the conference.
Maison Solutions Signs Consultancy Agreement with Four Good Fortune Supermarkets
MONTEREY PARK, CA / ACCESS Newswire / January 30, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, announced it has signed a three-year consultancy agreement with four Good Fortune Supermarkets located across Massachusetts, New York, Rhode Island, and Virginia, effective January 29, 2025. Under the agreement, Maison Solutions will leverage its knowledge and experience in supermarket operations and digitization to provide consulting services to enhance operational efficiency, marketing outreach, and business growth for each of the four supermarkets.
Maison Solutions Reports Second Quarter and Six-Month 2025 Financial Results
MONTEREY PARK, CA / ACCESSWIRE / December 16, 2024 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the second quarter and six-months ended October 31, 2024. Management Commentary "I am pleased to announce another quarter of sequential and year-over-year top-line growth, a clear reflection of the successful and immediate impacts of our Lee Lee acquisition," said John Xu, President, Chairman and Chief Executive Officer of Maison Solutions.
Maison Solutions Completes El Monte Store Renovation
MONTEREY PARK, CA / ACCESSWIRE / October 28, 2024 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, announced it has completed the renovation of its El Monte store. The El Monte store is the first in a planned series of renovations across multiple HK Good Fortune locations.
Maison Solutions Reports First Quarter 2025 Financial Results
MONTEREY PARK, CA / ACCESSWIRE / September 23, 2024 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the first quarter ended July 31, 2024. Management Commentary "We are pleased with our financial results for Q1 2025, as it marked the first full quarter with Lee Lee included under the Maison Solutions umbrella," said John Xu, President, Chairman and Chief Executive Officer of Maison Solutions.
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
- Confirmed partial responses (PRs) doubled to four since ASCO GI in MSS CRC patients without liver and peritoneal metastases for overall response rate (ORR) of 24% (4/17) with ADG126 10 mg/kg every three weeks (Q3W) in combination with pembrolizumab -
MAISON ALERT: Bragar Eagel & Squire, P.C. is Investigating Maison Solutions Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Maison Solutions Inc. (NASDAQ: MSS) on behalf of long-term stockholders following a class action complaint that was filed against Maison on January 2, 2024 with a Class Period of (a) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company's October 2023 initial public offering (“IPO” or the “Offering”); and/or (b) securities from October 5, 2023 to December 15, 2023. Our investigation concerns whether the board of directors of Maison have breached their fiduciary duties to the company.
Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced results from an investigator-sponsored trial (IST) of botensilimab and balstilimab (BOT/BAL) in the neoadjuvant setting for colon cancer. Data were presented at the 2024 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress in Munich, Germany. Dr. Pashtoon Kasi, the originator of this groundbreaking study,.
Syndax Announces Plans to Advance into Phase 1b Portion of Trial Evaluating Revumenib in Relapsed or Refractory Metastatic MSS CRC
– IDMC recommendation to advance based on favorable safety profile observed in Phase 1a portion of trial – WALTHAM, Mass. , June 6, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it has advanced into the Phase 1b portion of its Phase 1/2 proof-of-concept trial of revumenib, the Company's highly selective, oral menin inhibitor, as a monotherapy in patients with relapsed or refractory (R/R) metastatic microsatellite stable (MSS) colorectal cancer (CRC).
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced a novel analysis from the Phase 1b trial of botensilimab in combination with balstilimab (BOT/BAL) in relapsed/refractory microsatellite stable colorectal cancer (r/r MSS CRC) with no active liver metastases (NLM) will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024. The.
Maison Solutions Releases Post-Acquisition Webinar Detailing Recent Expansion into Arizona
MONTEREY PARK, CA / ACCESSWIRE / April 19, 2024 / Maison Solutions Inc. ("Maison Solutions" or the "Company"), (NASDAQ:MSS), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today released a pre-recorded webinar providing additional information on the three recently acquired Arizona-based Lee Lee International Supermarket chain markets. The webinar is available for replay via the investor relations section of the Company's website.
Maison Solutions to Share Additional Details Regarding Expansion into Arizona on Friday, April 19, 2024 at 11:00 a.m. ET
Acquisition of Three-Store Lee Lee International Supermarket to More than Double Size of Maison MONTEREY PARK, CA / ACCESSWIRE / April 15, 2024 / Maison Solutions Inc. ("Maison Solutions" or the "Company"), (NASDAQ:MSS), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, announced it will release a pre-recorded post-acquisition webinar on Friday, April 19, 2024 at 11:00 a.m. ET (8:00 a.m.
Maison Solutions Expands into Arizona with Acquisition of Three-Store Lee Lee International Supermarkets Chain
-- Transaction More than Doubles Size of Maison; Expands Geographic Footprint to New Region -- MONTEREY PARK, CA / ACCESSWIRE / April 10, 2024 / Maison Solutions Inc. ("Maison Solutions" or the "Company"), (NASDAQ:MSS), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced the acquisition of Lee Lee Oriental Supermart, Inc., a three-store supermarket chain operating under the name, Lee Lee International Supermarkets, in the greater Phoenix and Tucson metro areas. The Company acquired Lee Lee International Supermarkets through AZLL, LLC, an Arizona limited liability company and the Company's wholly-owned subsidiary.
Maison Solutions Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results
MONTEREY PARK, CA / ACCESSWIRE / March 18, 2024 / Maison Solutions Inc. ("Maison Solutions" or the "Company"), (NASDAQ:MSS), a U.S.-based specialty grocery retailer offering traditional Asian food and merchandise to modern consumers, today announced financial results for the third quarter and first nine months of fiscal 2024 ended January 31, 2024. "We continue to make considerable operational progress through store renovations, new store openings, and acquisitions of additional stores to efficiently grow our footprint," said John Xu, President and Chief Executive Officer of Maison Solutions.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Maison Solutions Inc. - MSS
NEW YORK , March 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Maison Solutions Inc. ("Maison Solutions" or the "Company") (NASDAQ: MSS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
MSS DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action – MSS
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Maison Solutions Inc. (NASDAQ: MSS): (1) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Maison Solutions' October 2023 initial public offering (the “IPO”); and/or (2) securities between October 5, 2023 and December 15, 2023, inclusive (the “Class Period”), of the important Marc.
MSS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - MSS
NEW YORK , March 2, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Maison Solutions Inc. (NASDAQ: MSS): (1) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Maison Solutions' October 2023 initial public offering (the "IPO"); and/or (2) securities between October 5, 2023 and December 15, 2023, inclusive (the "Class Period"), of the important March 4, 2024 lead plaintiff deadline. SO WHAT: If you purchased Maison Solutions securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
MSS Investors Have Opportunity to Lead Maison Solutions Inc. Securities Fraud Lawsuit
LOS ANGELES , Feb. 29, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Maison Solutions Inc. ("Maison" or the "Company") (NASDAQ: MSS). Class Period: October 5, 2023 – December 15, 2023 Lead Plaintiff Deadline: March 4, 2024 If you wish to serve as lead plaintiff of the Maison lawsuit, you can submit your contact information at www.glancylaw.com/cases/Maison-Solutions-Inc/.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maison Solutions
NEW YORK , Feb. 29, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maison Solutions Inc. ("Maison Solutions" or the "Company") (NASDAQ: MSS) and reminds investors of the March 4, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Maison Solutions To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in Maison Solutions (a) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's October 2023 initial public offering ("IPO" or the "Offering"); and/or (b) securities between October 5, 2023 and December 15, 2023, inclusive (the "Class Period")and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext.
MSS DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Maison Solutions Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 4 Deadline in Securities Class Action - MSS
NEW YORK, Feb. 24, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Maison Solutions Inc. (NASDAQ: MSS): (1) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Maison Solutions' October 2023 initial public offering (the "IPO"); and/or (2) securities between October 5, 2023 and December 15, 2023, inclusive (the "Class Period"), of the important March 4, 2024 lead plaintiff deadline. SO WHAT: If you purchased Maison Solutions securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
MAISON SOLUTIONS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Maison Solutions To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in Maison Solutions (a) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's October 2023 initial public offering ("IPO" or the "Offering"); and/or (b) securities between October 5, 2023 and December 15, 2023, inclusive (the "Class Period")and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/MSS.
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MSS
NEW YORK , Feb. 17, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Maison Solutions Inc. (NASDAQ: MSS): (1) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Maison Solutions' October 2023 initial public offering (the "IPO"); and/or (2) securities between October 5, 2023 and December 15, 2023, inclusive (the "Class Period"), of the important March 4, 2024 lead plaintiff deadline. SO WHAT: If you purchased Maison Solutions securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
MAISON SOLUTIONS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Maison Solutions To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in Maison Solutions (a) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's October 2023 initial public offering ("IPO" or the "Offering"); and/or (b) securities between October 5, 2023 and December 15, 2023, inclusive (the "Class Period")and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/MSS.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for MSS.